MedTrace Logo

Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials

NCT03538262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2023-06-12

Study results available
· View outcomes & findings →

Summary

An observational study to characterize and compare long-term clinical outcomes data collected remotely through periodic tele-visits, interactive smartphone app sessions, and web-based surveys in individuals with Parkinson's Disease (PD) who have completed the interventional phases of the STEADY-PD3 and SURE-PD3 clinical trials.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • Sage Bionetworks

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • The Parkinson Study Group

    collaborator NETWORK

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Michael A Schwarzschild, MD, PhD · Massachusetts General Hospital

  • Tanya Simuni, MD · Northwestern University

  • E. Ray Dorsey, MD, MBA · University of Rochester

  • Larsson Omberg, PhD · Sage Bionetworks

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2022-03-21
Completion
2022-03-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03538262 on ClinicalTrials.gov